Overview

Evaluation of Pharmacokinetic Interaction Between Micronized Fenofibrate and Pitavastatin

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
To evaluate pharmacokinetic drug interaction by comparing the steady-state pharmacokinetic characteristics of each arms after repeated administrating Lipilfen cap. 160mg and Livalo tab. 2mg through 3 period by separately or combinedly.
Phase:
Phase 1
Details
Lead Sponsor:
Hanlim Pharm. Co., Ltd.
Treatments:
Fenofibrate
Infliximab
Pitavastatin